For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

The incidence of early-onset colorectal cancer has been increasing worldwide, a trend that has coincided with growing intake ...

A research team at Queen’s University is seeking to understand how bowel cancer develops resistance to treatments including ...

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes associated with colorectal cancer are known, how they contribute to cancer ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...